These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16045196)

  • 1. [In vivo evaluation of expressed protein function by PET].
    Matsumoto R; Suhara T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):137-41. PubMed ID: 16045196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of PET in clinical trials of psychotropic drugs].
    Suhara T; Morimoto T
    Seishin Shinkeigaku Zasshi; 2005; 107(7):704-11. PubMed ID: 16250122
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular imaging in the drug development of psychotropics using positron emission tomography].
    Takano H; Takahashi H; Ito H; Suhara T
    Brain Nerve; 2007 Mar; 59(3):215-20. PubMed ID: 17370647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging neurochemical endophenotypes: promises and pitfalls.
    Martinez D; Broft A; Laruelle M
    Pharmacogenomics; 2001 Aug; 2(3):223-37. PubMed ID: 11535111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.
    Neumeister A; Young T; Stastny J
    Psychopharmacology (Berl); 2004 Aug; 174(4):512-24. PubMed ID: 15249991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of the serotonin transporter.
    Lesch KP; Gutknecht L
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1062-73. PubMed ID: 15951088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
    Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular imaging of psychiatric disorders].
    Takahashi H; Suhara T
    Nihon Rinsho; 2007 Feb; 65(2):336-41. PubMed ID: 17302281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
    Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
    Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter in vitro binding and in vivo imaging in the brain.
    Bergström KA; Tupala E; Tiihonen J
    Pharmacol Toxicol; 2001 Jun; 88(6):287-93. PubMed ID: 11453367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
    Shioe K; Ichimiya T; Suhara T; Takano A; Sudo Y; Yasuno F; Hirano M; Shinohara M; Kagami M; Okubo Y; Nankai M; Kanba S
    Synapse; 2003 Jun; 48(4):184-8. PubMed ID: 12687637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.
    Frankle WG; Lombardo I; New AS; Goodman M; Talbot PS; Huang Y; Hwang DR; Slifstein M; Curry S; Abi-Dargham A; Laruelle M; Siever LJ
    Am J Psychiatry; 2005 May; 162(5):915-23. PubMed ID: 15863793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.